United Therapeutics (UTHR) Return on Sales (2016 - 2025)
Historic Return on Sales for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to 0.42%.
- United Therapeutics' Return on Sales rose 100.0% to 0.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.53%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.42% for FY2024, which is 100.0% down from last year.
- United Therapeutics' Return on Sales amounted to 0.42% in Q3 2025, which was up 100.0% from 0.39% recorded in Q2 2025.
- United Therapeutics' Return on Sales' 5-year high stood at 217.1% during Q4 2023, with a 5-year trough of 38.14% in Q4 2024.
- In the last 5 years, United Therapeutics' Return on Sales had a median value of 0.41% in 2025 and averaged 9.76%.
- As far as peak fluctuations go, United Therapeutics' Return on Sales skyrocketed by 2168300bps in 2023, and later plummeted by -2552400bps in 2024.
- United Therapeutics' Return on Sales (Quarter) stood at 0.27% in 2021, then decreased by -1bps to 0.27% in 2022, then skyrocketed by 80676bps to 217.1% in 2023, then crashed by -118bps to 38.14% in 2024, then skyrocketed by 101bps to 0.42% in 2025.
- Its last three reported values are 0.42% in Q3 2025, 0.39% for Q2 2025, and 0.41% during Q1 2025.